PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

L-carnitine protects against carboplatin-mediated renal injury: AMPK- and PPARα-dependent inactivation of NFAT3.

Mixed / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25090113 ↗2014Reported benefit

L-carnitine protects against carboplatin-mediated renal injury: AMPK- and PPARα-dependent inactivation of NFAT3.

MixedChemical/toxinBALB/cMalen = 12 mice per group, except the compound C group with 16 mice…Intraperitoneal injection (in vivo)50 mg/kg in vivo; 5 mM in vitroPretreatment starting 2 days before the single carboplatin dose

Model: Carboplatin-induced renal tubular injury (single intraperitoneal carboplatin 75 mg/kg in vivo; 200 µM carboplatin challenge in renal tubular cells in vitro)

L-carnitine markedly reduced carboplatin-induced renal injury. Histological damage was milder, carboplatin-induced renal tubular cell apoptosis was inhibited by approximately 75%, and the carboplatin-induced rises in serum urea nitrogen and creatinine were significantly alleviated. Protection depen…

Extraction: extract · Supplied extraction confidence: 0.92. Machine-extracted fields require source verification.